NEW YORK (TheStreet) — Valeant Pharmaceuticals (VRX – Get Report) stock is slumping by 3.25% to $98.35 in afternoon trading on Monday after activist investor Bill Ackman"s Pershing Square Capital Management lowered its stake in the specialty … Read the full article on TheStreet.com »
Valeant (VRX) Stock Falls as Ackman Trims Stake to 8.5% - TheStreet.com
No comments:
Post a Comment